Who owns GlaxoSmithKline?

Key details on GlaxoSmithKline (Ticker: GSK)

Who owns GlaxoSmithKline?

Is GSK a good stock to own? Find out who bought GlaxoSmithKline, who sold GlaxoSmithKline (GSK) stock, and who holds a large position in GlaxoSmithKline.

Fund Name Number of Shares Share Valuation As Of
Dodge & Cox 60.48M $3.23B Dec. 31, 2013
Gruss & Co 25.33M $547.95M Sept. 30, 2012
Royal Bank of Canada 17.94M $958.46M Dec. 31, 2013
STATE STREET CORPORATION 11.37M $494.27M Dec. 31, 2013
Fisher Investments 11.21M $599.18M March 31, 2014
PRIMECAP Management Company 10.00M $533.84M Dec. 31, 2013
Bank of America Corporation 8.45M $451.22M Dec. 31, 2013
T. Rowe Price Associates 8.26M $440.84M Dec. 31, 2013
Wells Fargo & Company 8.12M $433.67M Dec. 31, 2013
FMR 6.75M $360.33M Dec. 31, 2013
FIDUCIARY MANAGEMENT INC /WI/ 6.14M $307.94M Sept. 30, 2013
Inves 5.90M $315.11M Dec. 31, 2013
Allianz Global Investors of America 5.45M $244.61M March 31, 2012
Tradewinds Global Investors 5.17M $240.43M Dec. 31, 2011
Ameriprise Financial 4.42M $201.33M June 30, 2012
GOLDMAN SACHS 3.93M $181.56M Sept. 30, 2012
Renaissance Technologies 3.89M $195.23M Sept. 30, 2013

Who sold GlaxoSmithKline?

Fund Name Date Sold Number of Shares Sold Share Valuation
ClearBridge Advisors Sept. 30, 2011 4.13M $170.73M
Brandes Investment Partners Sept. 30, 2011 3.81M $157.34M
Johnson Investment Counsel June 30, 2011 19.93M $947.34M